KIM GUSTAFSON: Open Payments
NPI 1164896056 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$517 in 27 payments from 10 companies in 2025. Trend: 2023 $1,099 · 2024 $893 · 2025 $517
Food & beverage: $517
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $135 |
| MILLICENT US INC | 5 | $86 |
| Exeltis, USA Inc. | 4 | $63 |
| Bausch Health US, LLC | 2 | $50 |
| Currax Pharmaceuticals LLC | 3 | $48 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $42 |
| Organon LLC | 1 | $30 |
| Astellas Pharma US Inc | 1 | $25 |
| Exact Sciences Corporation | 1 | $20 |
| CooperSurgical, Inc. | 1 | $17 |
Products named: MYFEMBREE, SLYND, APLENZIN, FEMLYV, CONTRAVE, FEMRING, NEXPLANON, Veozah.
Industry payments across TX — which companies pay providers there.
